Sintx Technologies (SINT) Cash from Investing Activities Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.07% |
| Dec 31, 2025 | -16.14% |
| Sep 30, 2025 | 5.44% |
| Jun 30, 2025 | -5.66% |
| Mar 31, 2025 | -16.64% |
| Dec 31, 2024 | -52.44% |
| Sep 30, 2024 | -16.07% |
| Mar 31, 2024 | -19.29% |
| Dec 31, 2023 | -19.79% |
| Sep 30, 2023 | 6.12% |
| Mar 31, 2023 | -36.39% |
| Dec 31, 2022 | -6.11% |
| Sep 30, 2022 | -4.51% |
| Jun 30, 2022 | 21.35% |
| Mar 31, 2022 | 4.66% |
| Dec 31, 2021 | -19.41% |
| Sep 30, 2021 | -105.80% |
| Jun 30, 2021 | 70.88% |
| Mar 31, 2021 | 29.70% |
| Dec 31, 2020 | 32.06% |
| Sep 30, 2020 | 58.84% |
| Jun 30, 2020 | 40.44% |
| Mar 31, 2020 | 28.07% |
| Dec 31, 2019 | 38.59% |
| Sep 30, 2019 | 19.60% |
| Jun 30, 2019 | 22.15% |
| Mar 31, 2019 | 22.02% |
| Dec 31, 2018 | 16.68% |
| Sep 30, 2018 | -17.54% |
| Mar 31, 2018 | -17.41% |